<p>(A, B) The left panels show representative images of CD11b (green) and IL-1β (red) or MR (red) in the granulation tissues of WT and <i>EP3</i><sup><i>–/–</i></sup>(A) or <i>EP4</i><sup><i>–/–</i></sup>(B) mice on day 3. Scale bars: 10 μm. The data are quantified in the right panel. Data are expressed as the mean ± SEM (n = 6). ***P < 0.001.</p
<p>(<b>A</b>) Immunohistochemical (IHC) images of PNA (dark blue) vs B220 (brown) expression in sple...
<p><b>A</b>) Percent (top, <i>p = 0</i>.<i>009</i>) and number (bottom, <i>p = 0</i>.<i>03</i>) of C...
<p>(A) Photographs of F4/80-positive cells at the damaged site on day 4 after femoral bone defect. S...
<p>(A–D) Real-time PCR analyses of the levels of the <i>LYVE-1</i> (A), <i>VEGFR-3</i> (B), <i>VEGF-...
<p>(A–D) Real-time PCR analyses of the levels of the <i>LYVE-1</i> (A), <i>VEGFR-3</i> (B), <i>VEGF-...
<p>C57BL/6J mice were wounded for 1 or 14 days, and the surface expression of MHC class II, CD11c an...
<p><b>A.</b> Spleen weights of mFADD<sup>-/-</sup> mice, their littermate controls (Ctl) and age-mat...
<p>A) Temporal changes in the closure of wounds in control and celecoxib-treated mice. Data are expr...
<p>(A) TNF-α, IL-6 and MCP-1 concentration on day 3 by ELISA (n = 6 per group). (B, C) HMGB1 (B) and...
<p>(A) Relative expression of marker genes for M1 (<i>Cd11c</i>) and M2 (<i>MR</i>, <i>Cd163</i>) ma...
<p>C57 mice received EPO or PBS sham treatment starting on the day of MOG-immunization for 6 days an...
<div><p>GM-IMs or PMφ were stimulated with 20 ng/mL IFNγ, 20 ng/mL IL-4 and 20 ng/mL IL-13 or ong µg...
<p><i>Il4ra<sup>−/lox</sup></i>, <i>LysM<sup>cre</sup>Il4ra<sup>−/lox</sup></i>, <i>iLck<sup>cre</su...
<p>(<b>A</b>) Representative photomicrographs of immunofluorescent-stained M1 (iNOS<sup>+</sup>) and...
<p>At day 7 post-surgery, the wound skin tissues were analyzed immunochemically and by qRT-PCR. Show...
<p>(<b>A</b>) Immunohistochemical (IHC) images of PNA (dark blue) vs B220 (brown) expression in sple...
<p><b>A</b>) Percent (top, <i>p = 0</i>.<i>009</i>) and number (bottom, <i>p = 0</i>.<i>03</i>) of C...
<p>(A) Photographs of F4/80-positive cells at the damaged site on day 4 after femoral bone defect. S...
<p>(A–D) Real-time PCR analyses of the levels of the <i>LYVE-1</i> (A), <i>VEGFR-3</i> (B), <i>VEGF-...
<p>(A–D) Real-time PCR analyses of the levels of the <i>LYVE-1</i> (A), <i>VEGFR-3</i> (B), <i>VEGF-...
<p>C57BL/6J mice were wounded for 1 or 14 days, and the surface expression of MHC class II, CD11c an...
<p><b>A.</b> Spleen weights of mFADD<sup>-/-</sup> mice, their littermate controls (Ctl) and age-mat...
<p>A) Temporal changes in the closure of wounds in control and celecoxib-treated mice. Data are expr...
<p>(A) TNF-α, IL-6 and MCP-1 concentration on day 3 by ELISA (n = 6 per group). (B, C) HMGB1 (B) and...
<p>(A) Relative expression of marker genes for M1 (<i>Cd11c</i>) and M2 (<i>MR</i>, <i>Cd163</i>) ma...
<p>C57 mice received EPO or PBS sham treatment starting on the day of MOG-immunization for 6 days an...
<div><p>GM-IMs or PMφ were stimulated with 20 ng/mL IFNγ, 20 ng/mL IL-4 and 20 ng/mL IL-13 or ong µg...
<p><i>Il4ra<sup>−/lox</sup></i>, <i>LysM<sup>cre</sup>Il4ra<sup>−/lox</sup></i>, <i>iLck<sup>cre</su...
<p>(<b>A</b>) Representative photomicrographs of immunofluorescent-stained M1 (iNOS<sup>+</sup>) and...
<p>At day 7 post-surgery, the wound skin tissues were analyzed immunochemically and by qRT-PCR. Show...
<p>(<b>A</b>) Immunohistochemical (IHC) images of PNA (dark blue) vs B220 (brown) expression in sple...
<p><b>A</b>) Percent (top, <i>p = 0</i>.<i>009</i>) and number (bottom, <i>p = 0</i>.<i>03</i>) of C...
<p>(A) Photographs of F4/80-positive cells at the damaged site on day 4 after femoral bone defect. S...